assembly Bill A2850

2017-2018 Legislative Session

Directs the health care quality and cost containment commission to study and report upon the impact of requiring that certain health insurance plans provide coverage for treatment of mitochondrial disease

download bill text pdf

Sponsored By

Archive: Last Bill Status - In Assembly Committee

  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor

Your Voice

do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

view actions (2)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
Jan 03, 2018 referred to health
Jan 23, 2017 referred to health

Co-Sponsors

A2850 (ACTIVE) - Details

Current Committee:
Assembly Health
Law Section:
Insurance Law
Laws Affected:
Amd §213, Ins L
Versions Introduced in 2015-2016 Legislative Session:
A7689

A2850 (ACTIVE) - Summary

Directs the health care quality and cost containment commission to study and report upon the impact of requiring that certain health insurance plans provide coverage for treatment of mitochondrial disease.

A2850 (ACTIVE) - Bill Text download pdf 


                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  2850

                       2017-2018 Regular Sessions

                          I N  A S S E M B L Y

                            January 23, 2017
                               ___________

Introduced by M. of A. McDONALD -- read once and referred to the Commit-
  tee on Health

AN ACT to amend the insurance law, in relation to directing the New York
  state health care quality and cost containment commission to study and
  report  upon  the  impact  of  requiring that certain health insurance
  plans provide coverage for treatment of mitochondrial disease

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. Section 213 of the insurance law is amended by adding a new
subsection (e) to read as follows:
  (E)  THE  COMMISSION SHALL CAUSE A STUDY TO BE PERFORMED ON THE IMPACT
OF REQUIRING CERTAIN HEALTH INSURANCE  PLANS  TO  PROVIDE  COVERAGE  FOR
TREATMENT  OF MITOCHONDRIAL DISEASE. SUCH STUDY SHALL INCLUDE AN ASSESS-
MENT OF THE IMPACT OF SUCH A REQUIREMENT ON COSTS TO PROVIDERS, THE COST
OF INSURANCE PREMIUMS, AND THE FISCAL IMPACT TO THE STATE.  THE  COMMIS-
SION  SHALL SUBMIT A REPORT OF THE FINDINGS, CONCLUSIONS AND RECOMMENDA-
TION OF SUCH STUDY, ON OR BEFORE NOVEMBER THIRTIETH, TWO THOUSAND  EIGH-
TEEN,  TO  THE  GOVERNOR,  THE  TEMPORARY  PRESIDENT  OF THE SENATE, THE
SPEAKER OF THE ASSEMBLY, THE CHAIRS OF THE SENATE AND ASSEMBLY INSURANCE
COMMITTEES, AND THE CHAIRS OF THE SENATE AND ASSEMBLY HEALTH COMMITTEES.
  § 2. This act shall take effect immediately.




 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD00580-01-7